GlassScriptPhysician profile
Chaitra Mohan
NPI 1396163119
$45,077.46
in general payments reported to CMS, 2019-2025
29 companies · $6,628 in 2025
The $6,628 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $5,908 · 2021: $11K · 2022: $9,941 · 2023: $4,242 · 2024: $4,903 · 2025: $6,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,288 · Travel and Lodging: $6,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,287.94 |
| Travel and Lodging | $6,484.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,544.48 | 2021-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $7,871.02 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic Vascular, INC. | $6,845.66 | 2019-2020 | |
| Biotronik INC. | $5,414.21 | 2021-2022 | |
| Boston Scientific Corporation | $3,376.96 | 2019-2025 | Watchman Flx, General - Therapies, Watchman |
| Cardiva Medical, INC. | $362.09 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $361.85 | 2022-2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $334.13 | 2019-2025 | Wainua |
| Pfizer INC. | $303.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $290.27 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $281.47 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $237.27 | 2022-2025 | Camzyos, Eliquis |
| Lexicon Pharmaceuticals, INC. | $165.41 | 2023-2024 | Inpefa |
| Akcea Therapeutics, INC. | $93.12 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $84.32 | 2025 | Uptravi, Opsynvi, Opsumit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $82.83 | 2022-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $73.79 | 2024-2025 | Assure Wcd |
| Biosense Webster, INC. | $73.35 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $46.27 | 2024 | Arcalyst |
| Amgen INC. | $39.23 | 2023-2024 | Repatha |
| Bridgebio Pharma, INC. | $33.59 | 2025 | Attruby |
| Humacyte Global, INC. | $29.67 | 2025 | Symvess |
| Abiomed | $24.67 | 2023 | Impella |
| Sobi, INC | $22.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2025 | |
| Novo Nordisk INC | $17.10 | 2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $17.09 | 2023 | |
| Baxter Healthcare | $16.72 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaitra Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.